3-Fluoro-N-(piperidin-4-yl)pyridin-4-amine trihydrochloride, 1g

2-Amino-4-methoxy-6-methylpyrimidine, 98.0%, 25g

N,N'-Bis[4-di(m-tolyl)aminophenyl]-N,N'-diphenylbenzidine>98.0%(HPLC)5g

trans-tert-Butyl 3-(hydroxymethyl)-4-methylpyrrolidine-1-carboxylate, 95.0%, 1g

Boc-�-HoAsp(OBzl)-OH, 95%, 5g

Plan fase 20x/0,40 objetivo corregido al infinito

Biotinmethylester, 97.0%, 5g

1-(4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanone, 95.0%, 5g

((1R,2S)-2-Aminocyclohexyl)methanol, 97%, 500mg

1-[(4-bromophenyl)sulfonyl]piperidine-2-carboxylic acid, 95.0%, 250mg

Benzo[d]oxazole-6-carbaldehyde, 95.0%, 250mg

2,6-Dichloro-3-methoxyaniline, 97%, 1g

1-(4-Aminophenyl)cyclopropanecarboxylic acid, 97%, 5g